Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VTRS · against 102 other Healthcare companies of similar size
Ranked #64 of 103 · scores higher than 38% of peers
Bars: peers in each 10-point band of the valuation score17 peers with a valuation score of 50–59, including VTRS · Click a bar to see the companies
A mix: stronger free cash flow yield and EBITDA yield, but weaker earnings yield than most Healthcare peers.
| Metric | VTRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 101 reported | -2.0% | 3.2% | 7% | 30% | |
| EBITDA yieldHigher is better · 103 reported | 12.7% | 5.9% | 91% | 50% | |
| Free cash flow yieldHigher is better · 62 reported | 8.3% | 3.9% | 90% | 20% | |
| Book yieldHigher is better · 97 reported | 66.5% | 21.7% | 92% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 2 | 21.5B USD | 95 | 60 | |
| 4 | 11.6B USD | 94 | 58 | |
| 4 | 68.0B BRL (≈$12.2B) | 94 | 67 | |
| 60 | 166.5B SEK (≈$16.6B) | 54 | 49 | |
| 60 | 16.1B CHF (≈$18.5B) | 54 | 54 | |
| 62 | 13.8B USD | 53 | 54 | |
| 62 | 14.6B USD | 53 | 59 | |
| 64 | 21.7B USD | 52 | 32 | |
| 65 | 34.6B USD | 51 | 58 | |
| 65 | 18.5B USD | 51 | 62 | |
| 65 | 34.0B USD | 51 | 49 | |
| 65 | 11.9B USD | 51 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score